1. bookVolume 4 (2021): Issue 1 (June 2021)
Journal Details
License
Format
Journal
eISSN
2544-8978
First Published
30 May 2018
Publication timeframe
1 time per year
Languages
English
access type Open Access

When an old pigmented lesion becomes serious: the problematic diagnosis of low-grade skin malignancies – Bednar tumor with fibrosarcomatous transformation

Published Online: 13 Aug 2021
Volume & Issue: Volume 4 (2021) - Issue 1 (June 2021)
Page range: 16 - 23
Accepted: 22 Jul 2021
Journal Details
License
Format
Journal
eISSN
2544-8978
First Published
30 May 2018
Publication timeframe
1 time per year
Languages
English
Abstract

Bednar tumor is a rare cutaneous neoplasm, regarded as a variant of dermatofibrosarcoma protuberans with melanotic colonization and it usually affects young and middle-aged adults or children. This lesion is considered a low-grade malignant tumor, which can be associated with multiple local recurrences after surgical excision. Although a rare phenomenon, these lesions may undergo fibrosarcomatous transformation, which implies a poorer prognosis of the disease, as the tumor has a more locally aggressive behavior and patients might also develop distant metastases.

We present the case of a 53-year-old female patient, with no significant medical history, who presented with a subcutaneous nodule on her upper back, for which a wide surgical excision was performed. The gross examination of the specimen showed a solitary protuberant grey-white nodule with a bluish shade and flecked with pigment. The microscopic examination revealed a malignant proliferation with a predominantly fascicular growth pattern, composed of spindle cells with highly pleomorphic nuclei and high mitotic rate, as well as the presence of dendritic cells with abundant melanin. Upon immunohistochemical analysis, the proliferation showed negative staining for CD 34 and AE 1/3, whereas the scattered dendritic cells stained positive with S100 protein. Ki 67 was positive in 15% of the tumor cells and the absence of p53 expression was noted. Thus, the diagnosis of Bednar tumor with fibrosarcomatous transformation was established.

The aim of this paper was to gain further knowledge about the histopathological and immunohistochemical features, as well as about the treatment of Bednar tumor, especially considering its rarity.

Keywords

1. Thway K, Noujaim J, Jones RL, Fisher C. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies. Ann Diagn Pathol. 2016 Dec; 25:64-71. doi: 10.1016/j.anndiagpath.2016.09.013.10.1016/j.anndiagpath.2016.09.01327806849 Search in Google Scholar

2. Reha J, Katz SC. Dermatofibrosarcoma Protuberans. Surg Clin North Am. 2016 Oct; 96(5):1031-46. doi: 10.1016/j.suc.2016.05.006.10.1016/j.suc.2016.05.00627542641 Search in Google Scholar

3. Llombart B, Serra-Guillén C, Monteagudo C, López Guerrero JA, Sanmartín O. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 2013 Feb; 30(1):13-28. doi: 10.1053/j.semdp.2012.01.002.10.1053/j.semdp.2012.01.00223327727 Search in Google Scholar

4. Orlandi A, Bianchi L, Spagnoli LG. Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features. J Cutan Pathol. 1998 Aug; 25(7):386-93. doi: 10.1111/j.1600-0560.1998.tb01763.x.10.1111/j.1600-0560.1998.tb01763.x9765025 Search in Google Scholar

5. Almeida FT, Carvalho SD, Pereira T, Brito C. When a bruise gets important: Bednar tumour. BMJ Case Rep. 2019 Feb 11; 12(2):e228446. doi: 10.1136/bcr-2018-228446.10.1136/bcr-2018-228446638194430755432 Search in Google Scholar

6. Ferlosio A, Di Prete M, Rossi P, Campione E, Orlandi A. Bednar Tumour Occurring after Malignant Melanoma Excision. Case Rep Pathol. 2018 Oct 1; 2018:7694272. doi: 10.1155/2018/7694272.10.1155/2018/7694272618885730364040 Search in Google Scholar

7. Añón-Requena MJ, Pico-Valimaña M, Muñoz-Arias G. Bednar Tumor (Pigmented Dermatofibrosarcoma Protuberans). Actas Dermosifiliogr. 2016 Sep; 107(7):618-20. doi: 10.1016/j.ad.2015.10.017.10.1016/j.ad.2015.10.01726945477 Search in Google Scholar

8. Kaul R, Kaur N, Dogra SS, Chander B. Variant of dermatofibrosarcoma protuberans: bednar tumor. Indian J Dermatol. 2015 Jan-Feb; 60(1):107. doi: 10.4103/0019-5154.147885.10.4103/0019-5154.147885431804725657441 Search in Google Scholar

9. Bednar B. Storiform neurofibromas of the skin, pigmented and nonpigmented. Cancer. 1957 Mar-Apr; 10(2):368-76. doi: 10.1002/1097-0142(195703/04)10:2<368:aid-cncr2820100218>3.0.co;2-3. Search in Google Scholar

10. Fletcher CD, Theaker JM, Flanagan A, Krausz T. Pigmented dermatofibrosarcoma protuberans (Bednar tumour): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study. Histopathology. 1988 Dec; 13(6):631-43. doi: 10.1111/j.1365-2559.1988.tb02094.x.10.1111/j.1365-2559.1988.tb02094.x2466752 Search in Google Scholar

11. Kreicher KL, Kurlander DE, Gittleman HR, Barnholtz-Sloan JS, Bordeaux JS. Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States. Dermatol Surg. 2016 Jan; 42 Suppl 1:S24-31. doi: 10.1097/DSS.0000000000000300.10.1097/DSS.000000000000030026730971 Search in Google Scholar

12. Amonkar GP, Rupani A, Shah A, Deshpande R. Bednar Tumor: An Uncommon Entity. Dermatopathology (Basel). 2016 Apr 20; 3(2):36-8. doi: 10.1159/000445714.10.1159/000445714496553827504443 Search in Google Scholar

13. Jing C, Zhang H, Zhang X, Yu S. Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution. Dermatol Surg. 2021 Feb 1; 47(2):e26-e30. doi: 10.1097/DSS.0000000000002578.10.1097/DSS.000000000000257832769521 Search in Google Scholar

14. Allen A, Ahn C, Sangüeza OP. Dermatofibrosarcoma Protuberans. Dermatol Clin. 2019 Oct; 37(4):483-488. doi: 10.1016/j.det.2019.05.006.10.1016/j.det.2019.05.00631466588 Search in Google Scholar

15. Hayakawa K, Matsumoto S, Ae K, Tanizawa T, Gokita T, Funauchi Y, Motoi N. Risk factors for distant metastasis of dermatofibrosarcoma protuberans. J Orthop Traumatol. 2016 Sep; 17(3):261-6. doi: 10.1007/s10195-016-0415-x.10.1007/s10195-016-0415-x499938027289468 Search in Google Scholar

16. Stacchiotti S, Pedeutour F, Negri T, Conca E, Marrari A, Palassini E, Collini P, Keslair F, Morosi C, Gronchi A, Pilotti S, Casali PG. Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib. Int J Cancer. 2011 Oct 1; 129(7):1761-72. doi: 10.1002/ijc.25826. Erratum in: Int J Cancer. 2017 May 15; 140(10):E13.10.1002/ijc.2582621128251 Search in Google Scholar

17. Lopez LV, Yatsenko SA, Burgess M, Schoedel K, Rao UNM. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: our experience, molecular evaluation of selected cases, and short literature review. Int J Dermatol. 2019 Nov; 58(11):1246-1252. doi: 10.1111/ijd.14462.10.1111/ijd.1446230968395 Search in Google Scholar

18. Brooks J, Ramsey ML. Dermatofibrosarcoma Protuberans. 2021 Feb 15. In: StatPearls, 2021 Jan, Treasure Island (FL), StatPearls Publishing. Search in Google Scholar

19. González A, Etchichury D, Rivero JM, Adamo L. Treatment of dermatofibrosarcoma of the head and neck with Mohs surgery with paraffin sections. J Plast Reconstr Aesthet Surg. 2021 May; 74(5):1061-1070. doi: 10.1016/j.bjps.2020.10.062.10.1016/j.bjps.2020.10.06233317985 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo